EP Patent
EP3063135A1 — Process for the preparation of enzalutamide
Assigned to Sun Pharmaceutical Industries Ltd · Expires 2016-09-07 · 10y expired
What this patent protects
The present invention provides a process for the preparation of enzalutamide.
USPTO Abstract
The present invention provides a process for the preparation of enzalutamide.
Drugs covered by this patent
- Xtandi (enzalutamide) · Astellas Pharma
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.